Not applicableStudy completedNCT01965223
What this trial is testing
Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)
Who this might be right for
CancerMetastases to the Lung
Trans Tasman Radiation Oncology Group 90